Jobs News Biogen To Cut 1,000 Jobs As Focus Turns To Alzheimer S Drug Leqembi Launch
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Jobs News Biogen To Cut 1,000 Jobs As Focus Turns To Alzheimer S Drug Leqembi Launch is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Biogen Cuts Profit Guidance After Deals to Bolster Pipeline
(Bloomberg) -- Biogen Inc. cut its full-year profit guidance on higher costs from deals the company has been doing to offset the decline of its aging multiple sclerosis drugs. The drugmaker now ... Read More
Biogen boosts sales outlook on 'resilient' legacy MS franchise as new launches build momentum
As momentum for Biogen’s newer drugs for neurological disorders builds at a slow and steady pace, it appears that the company can still count on its older products to hold down the fort and support ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus